Accuracy of MicroRNAs As Markers for the Detection of Neck Lymph Node Metastases in Patients with Head and Neck Squamous Cell Carcinoma

Overview

Journal BMC Med

Publisher Biomed Central

Specialty General Medicine

Date 2015 May 10

PMID 25956054

Citations 19

Authors

Ana Carolina de Carvalho

Cristovam Scapulatempo-Neto

Danielle Calheiros Campelo Maia

Adriane Feijo Evangelista

Mariana Andozia Morini

Andre Lopes Carvalho

Andre Luiz Vettore

Affiliations

Soon will be listed here.

Abstract

Background: The presence of metastatic disease in cervical lymph nodes of head and neck squamous cell carcinoma (HNSCC) patients is a very important determinant in therapy choice and prognosis, with great impact in overall survival. Frequently, routine lymph node staging cannot detect occult metastases and the post-surgical histologic evaluation of resected lymph nodes is not sensitive in detecting small metastatic deposits. Molecular markers based on tissue-specific microRNA expression are alternative accurate diagnostic markers. Herein, we evaluated the feasibility of using the expression of microRNAs to detect metastatic cells in formalin-fixed paraffin-embedded (FFPE) lymph nodes and in fine-needle aspiration (FNA) biopsies of HNSCC patients.

Methods: An initial screening compared the expression of 667 microRNAs in a discovery set comprised by metastatic and non-metastatic lymph nodes from HNSCC patients. The most differentially expressed microRNAs were validated by qRT-PCR in two independent cohorts: i) 48 FFPE lymph node samples, and ii) 113 FNA lymph node biopsies. The accuracy of the markers in identifying metastatic samples was assessed through the analysis of sensitivity, specificity, accuracy, negative predictive value, positive predictive value, and area under the curve values.

Results: Seven microRNAs highly expressed in metastatic lymph nodes from the discovery set were validated in FFPE lymph node samples. MiR-203 and miR-205 identified all metastatic samples, regardless of the size of the metastatic deposit. Additionally, these markers also showed high accuracy when FNA samples were examined.

Conclusions: The high accuracy of miR-203 and miR-205 warrant these microRNAs as diagnostic markers of neck metastases in HNSCC. These can be evaluated in entire lymph nodes and in FNA biopsies collected at different time-points such as pre-treatment samples, intraoperative sentinel node biopsy, and during patient follow-up. These markers can be useful in a clinical setting in the management of HNSCC patients from initial disease staging and therapy planning to patient surveillance.

Citing Articles

Does the Necrotic Portion of Metastatic Lymphadenopathy from Squamous Cell Carcinoma Still Have Tumoral Oncologic Information? Differential Diagnosis of Benign Necrotic Lymphadenopathy Using microRNA.

Shin E, Han S, Park I, Wee J, Lee J, Kim H Biomedicines. 2023; 11(9).

PMID: 37760848 PMC: 10525664. DOI: 10.3390/biomedicines11092407.

The performance of Ga-FAPI-04 PET/CT in head and neck squamous cell carcinoma: a prospective comparison with F-FDG PET/CT.

Jiang Y, Wen B, Li C, Tian Y, Xiao Z, Xu K Eur J Nucl Med Mol Imaging. 2023; 50(7):2114-2126.

PMID: 36808001 DOI: 10.1007/s00259-023-06138-y.

Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.

Thomaidou A, Batsaki P, Adamaki M, Goulielmaki M, Baxevanis C, Zoumpourlis V Int J Mol Sci. 2022; 23(15).

PMID: 35897831 PMC: 9367895. DOI: 10.3390/ijms23158257.

Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck.

Iacob R, Mandea M, Iacob S, Pietrosanu C, Paul D, Hainarosie R Front Med (Lausanne). 2022; 9:827297.

PMID: 35572996 PMC: 9098838. DOI: 10.3389/fmed.2022.827297.

miR-22 and miR-205 Drive Tumor Aggressiveness of Mucoepidermoid Carcinomas of Salivary Glands.

Naakka E, Barros-Filho M, Adnan-Awad S, Al-Samadi A, Marchi F, Kuasne H Front Oncol. 2022; 11:786150.

PMID: 35223452 PMC: 8864291. DOI: 10.3389/fonc.2021.786150.

References

He L, Hannon G . MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5(7):522-31. DOI: 10.1038/nrg1379. View

Heilo A, Sigstad E, Fagerlid K, Haskjold O, Groholt K, Berner A . Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma. J Clin Endocrinol Metab. 2011; 96(9):2750-5. DOI: 10.1210/jc.2010-2952. View

Olson P, Lu J, Zhang H, Shai A, Chun M, Wang Y . MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev. 2009; 23(18):2152-65. PMC: 2751988. DOI: 10.1101/gad.1820109. View

Kuntz A, Weymuller Jr E . Impact of neck dissection on quality of life. Laryngoscope. 1999; 109(8):1334-8. DOI: 10.1097/00005537-199908000-00030. View

van Diest P, Torrenga H, Meijer S, Meijer C . Pathologic analysis of sentinel lymph nodes. Semin Surg Oncol. 2001; 20(3):238-45. DOI: 10.1002/ssu.1039. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Barrera J, Miller M, Said S, Jafek B, Campana J, Shroyer K . Detection of occult cervical micrometastases in patients with head and neck squamous cell cancer. Laryngoscope. 2003; 113(5):892-6. DOI: 10.1097/00005537-200305000-00022. View

Rhee D, Wenig B, Smith R . The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck. Laryngoscope. 2002; 112(11):1970-4. DOI: 10.1097/00005537-200211000-00011. View

Lu J, Getz G, Miska E, Alvarez-Saavedra E, Lamb J, Peck D . MicroRNA expression profiles classify human cancers. Nature. 2005; 435(7043):834-8. DOI: 10.1038/nature03702. View

10.

Enepekides D, Sultanem K, Nguyen C, Shenouda G, Black M, Rochon L . Occult cervical metastases: immunoperoxidase analysis of the pathologically negative neck. Otolaryngol Head Neck Surg. 1999; 120(5):713-7. DOI: 10.1053/hn.1999.v120.a91761. View

11.

Nagadia R, Pandit P, Coman W, Cooper-White J, Punyadeera C . miRNAs in head and neck cancer revisited. Cell Oncol (Dordr). 2013; 36(1):1-7. DOI: 10.1007/s13402-012-0122-4. View

12.

Schiefke F, Akdemir M, Weber A, Akdemir D, Singer S, Frerich B . Function, postoperative morbidity, and quality of life after cervical sentinel node biopsy and after selective neck dissection. Head Neck. 2009; 31(4):503-12. DOI: 10.1002/hed.21001. View

13.

Ferracin M, Pedriali M, Veronese A, Zagatti B, Gafa R, Magri E . MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin. J Pathol. 2011; 225(1):43-53. PMC: 4325368. DOI: 10.1002/path.2915. View

14.

Hui A, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W . Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res. 2010; 16(4):1129-39. DOI: 10.1158/1078-0432.CCR-09-2166. View

15.

Ferlito A, Rinaldo A, Robbins K, Silver C . Neck dissection: past, present and future?. J Laryngol Otol. 2005; 120(2):87-92. DOI: 10.1017/S0022215105004512. View

16.

Ambrosch P, Brinck U . Detection of nodal micrometastases in head and neck cancer by serial sectioning and immunostaining. Oncology (Williston Park). 1996; 10(8):1221-6; discussion 1226, 1229. View

17.

Elsheikh M, Rinaldo A, Hamakawa H, Mahfouz M, Rodrigo J, Brennan J . Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma. Head Neck. 2006; 28(9):842-9. DOI: 10.1002/hed.20368. View

18.

Thomsen J, Christensen R, Sorensen J, Krogdahl A . Sentinel lymph nodes in cancer of the oral cavity: is central step-sectioning enough?. J Oral Pathol Med. 2007; 36(7):425-9. DOI: 10.1111/j.1600-0714.2007.00538.x. View

19.

Rodrigo J, Shah J, Silver C, Medina J, Takes R, Robbins K . Management of the clinically negative neck in early-stage head and neck cancers after transoral resection. Head Neck. 2011; 33(8):1210-9. DOI: 10.1002/hed.21505. View

20.

Ruopp M, Perkins N, Whitcomb B, Schisterman E . Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J. 2008; 50(3):419-30. PMC: 2515362. DOI: 10.1002/bimj.200710415. View